OCT-1–mediated influx is a key determinant of the intracellular uptake of imatinib but not nilotinib (AMN107): reduced OCT-1 activity is the cause of low in vitro sensitivity to imatinib

Deborah L. White, Verity A. Saunders, Phuong Dang, Jane Engler, Andrew C. W. Zannettino, Antony C. Cambareri, Steven R. Quinn, Paul W. Manley, Timothy P. Hughes

Open source

DOI
10.1182/blood-2005-11-4687
Published
2006-07-15
Container
Blood
Publisher
American Society of Hematology
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1182/blood-2005-11-4687,
  title = {OCT-1–mediated influx is a key determinant of the intracellular uptake of imatinib but not nilotinib (AMN107): reduced OCT-1 activity is the cause of low in vitro sensitivity to imatinib},
  author = {Deborah L. White and Verity A. Saunders and Phuong Dang and Jane Engler and Andrew C. W. Zannettino and Antony C. Cambareri and Steven R. Quinn and Paul W. Manley and Timothy P. Hughes},
  year = {2006},
  journal = {Blood},
  doi = {10.1182/blood-2005-11-4687},
  url = {https://doi.org/10.1182/blood-2005-11-4687}
}

RIS

TY  - JOUR
TI  - OCT-1–mediated influx is a key determinant of the intracellular uptake of imatinib but not nilotinib (AMN107): reduced OCT-1 activity is the cause of low in vitro sensitivity to imatinib
AU  - Deborah L. White
AU  - Verity A. Saunders
AU  - Phuong Dang
AU  - Jane Engler
AU  - Andrew C. W. Zannettino
AU  - Antony C. Cambareri
AU  - Steven R. Quinn
AU  - Paul W. Manley
AU  - Timothy P. Hughes
PY  - 2006
JO  - Blood
DO  - 10.1182/blood-2005-11-4687
UR  - https://doi.org/10.1182/blood-2005-11-4687
ER  - 

APA

White, D. L., Saunders, V. A., Dang, P., Engler, J., Zannettino, A. C. W., Cambareri, A. C., Quinn, S. R., Manley, P. W., & Hughes, T. P. (2006). OCT-1–mediated influx is a key determinant of the intracellular uptake of imatinib but not nilotinib (AMN107): reduced OCT-1 activity is the cause of low in vitro sensitivity to imatinib. Blood. https://doi.org/10.1182/blood-2005-11-4687

Source records